Impact of Diabetes on Epidemiology, Treatment, and Outcomes of Patients With Heart Failure

Cited by (400)

Items 201–300 of 400

1. MIRNA146a And Diabetes-Related Complications: A Review
   Ni Putu Tesi Maratni, Made Ratna Saraswati, Ni Nyoman Ayu Dewi, Ketut Suastika · 2022 · Current Diabetes Reviews
2. Assessing Impact of High-Dose Pitavastatin on Carotid Artery Elasticity with Speckle-Tracking Strain Imaging
   Chee Hae Kim, Shuang Wang, Jun‐Bean Park, Keun‐Hwa Jung, Yeonyee Elizabeth Yoon, Seung‐Pyo Lee, Hyung‐Kwan Kim, Yong-Jin Kim, Goo‐Yeong Cho, Dae‐Won Sohn · 2018 · Journal of Atherosclerosis and Thrombosis
3. Heart failure and diabetes mellitus: insight into comorbidity
   Nina Alexandrovna Petunina, Трухин Иван Викторович, Liubov V. Trukhina, Zhanna M. Sizova, Valeria L. Zakharova · 2019 · Diabetes Mellitus
4. Towards quadruple therapy for heart failure with reduced ejection fraction: DAPA-HF secondary analysis data
   Zh. D. Kobalava, Vadim Medovchshikov, Nurlan Yeshniyazov · 2020 · Russian Journal of Cardiology
5. Role of microvascular dysfunction in left ventricular dysfunction in type 2 diabetes mellitus
   Amera Halabi, Mark T. Nolan, Elizabeth Louise Potter, Leah M. Wright, Atef Asham, Thomas Hugh Marwick · 2021 · Journal of Diabetes and its Complications
6. Epigenetic Network in Immunometabolic Disease
   Martin Andreas Geiger, Era Gorica, S A Mohammed, Alessia Mongelli, Alessandro Mengozzi, Valentina Delfine, Frank Thomas Ruschitzka, Sarah Costantino, Francesco Paneni · 2023 · Advanced Biology
7. Mitochondrial shaping proteins as novel treatment targets for cardiomyopathies.
   Siavash Beikoghli Kalkhoran, Sauri Hernández‐Reséndiz, Sang‐Ging Ong, Chrishan J. A. Ramachandra, Derek John Hausenloy · 2020 · PubMed
8. Metabo-epigenetic circuits of heart failure: chromatin-modifying enzymes as determinants of metabolic plasticity
   Mark E. Pepin, Xuemin Gong, Almut Schulze, Johannes Backs · 2025 · EMBO Molecular Medicine
9. The modern paradigm of pathophysiology, prevention and treatment of heart failure in type 2 diabetes mellitus
   Ж. Д. Кобалава, Vadim Medovchshikov, Nurlan Yeshniyazov, Э. Р. Хасанова · 2019 · Russian Journal of Cardiology
10. Primary Prevention of CVD with Aspirin: Benefits vs Risks
    Weisman · 2021 · The Journal of Family Practice
11. Heart Failure and Diabetes Mellitus: Defining the Problem and Exploring the Interrelationship
    Michael J. Wilkinson, Adena Zadourian, Pam R. Taub · 2019 · The American Journal of Medicine
12. Efficacy and Safety of Naproxen for Acute Pain
    Steven R Weisman · 2020 · The Journal of Family Practice
13. Important Considerations for the Treatment of Patients with Diabetes Mellitus and Heart Failure from a Diabetologist’s Perspective: Lessons Learned from Cardiovascular Outcome Trials
    Chrysi C. Koliaki, Nicholas L. Katsilambros · 2019 · International Journal of Environmental Research and Public Health
14. Impact of empagliflozin on insulin needs in patients with heart failure and diabetes: An EMPEROR‐Pooled analysis
    Khawaja Muhammad Talha, Jennifer Green, Gerasimos S Filippatos, Stuart Pocock, Faiez M. Zannad, Martina Brueckmann, Elke Schueler, Anne Pernille Ofstad, João Pedro Ferreira, Stefan D. Anker et al. · 2024 · Diabetes Obesity and Metabolism
15. Association between glucose-to-lymphocyte ratio and mortality in patients with heart failure from the MIMIC-IV database: a retrospective cohort study
    Gang Wu, Huanya Ke, Zijia Tong, Jie Yang, Juan Yang, Zhengjun Shen · 2025 · Scientific Reports
16. Unveiling myocardial microstructure shifts: exploring the impact of diabetes in stable CAD patients through CMR T1 mapping
    Gustavo André Boeing Boros, Whady Armindo Hueb, Paulo Cury Rezende, Carlos Eduardo Rochitte, César Higa Nomura, Eduardo Gomes Lima, Matheus de Oliveira Laterza Ribeiro, Anderson Roberto Dallazen, Rosa Maria Rahmi Garcia, José Antônio Franchini Ramires et al. · 2024 · Diabetology & Metabolic Syndrome
17. Meta-Analysis Comparing Risk for Adverse Outcomes After Left Ventricular Assist Device Implantation in Patients With Versus Without Diabetes Mellitus
    Noman Lateef, Muhammad Usman, P.C. Colombo, Saba Ahmed, Muhammad Shahzeb Khan, Safi Ullah Khan, Arthur Reshad Garan, melana yuzefpolskaya, Ryan T. Demmer · 2019 · The American Journal of Cardiology
18. Analysis of National Health and Insurance Registers for All-Cause Mortality in Patients with Heart Failure with and without Diabetes Mellitus in Poland in 2012
    Waldemar Wierzba, Adam Wierzba, Andrzej M. Śliwczyński, Waldemar Karnafel, Jarosław Pinkas, Mariusz Gujski · 2019 · Medical Science Monitor
19. Subclinical left ventricular dysfunction in patients with type 2 diabetes mellitus
    V. A. Tsvetkov, Е. С. Крутиков, Svetlana Chistyakova · 2020 · Problems of Endocrinology
20. Managing the Burden of Dementia-Related Delusions and Hallucinations
    Small · 2020 · The Journal of Family Practice
21. Can Iron Play a Crucial Role in Maintaining Cardiovascular Health in the 21st Century?
    Michał Szklarz, Katarzyna Gontarz-Nowak, Wojciech Matuszewski, Elżbieta Maria Bandurska-Stankiewicz · 2022 · International Journal of Environmental Research and Public Health
22. Fibroblast Growth Factor 23: Potential Marker of Invisible Heart Damage in Diabetic Population
    Anna Kurpas, Karolina Supeł, Paulina Wieczorkiewicz, Joanna Bodalska Duleba, Marzenna Zielińska · 2023 · Biomedicines
23. Effect of Cardiac Resynchronization Therapy in Patients with Diabetes Randomized in EchoCRT
    Matthias P. Nägele, Jan Steffel, Michele Robertson, Jagmeet P. Singh, Andreas J. Flammer, Jeroen Joost Bax, JEFFREY S. BORER, Kenneth Dickstein, Ian Ford, John Gorcsan et al. · 2016 · European Journal of Heart Failure
24. Cardiac Computed Tomography Angiographic Findings as Predictors of Late Heart Failure in an Asymptomatic Diabetic Cohort: An 8-Year Prospective Follow-Up Study
    David A. Halon, Ayman Jubran, Ronen Rubinshtein, Barak Zafrir, Mali Azencot, Basil S. Lewis · 2017 · Cardiology
25. Natural and Synthetic Compounds for Management, Prevention and Treatment of Obesity
    Antonella D’Anneo, Marianna Lauricella · 2022 · International Journal of Molecular Sciences
26. New Therapeutic Target in Heart Failure
    Nancy K. Sweitzer, Sophia E. Airhart · 2018 · Circulation
27. Aging and Heart Failure with Preserved Ejection Fraction
    Kathryn F. Larson, Awais Malik, Frank V. Brozovich · 2022 · Comprehensive physiology
28. Prediabetes, Subclinical Myocardial Injury or Stress, and Heart Failure Risk for Adults With Hypertension
    Arnaud D. Kazé, Stephen Paul Juraschek, Jordana B. Cohen, Siddharth Singh, Chiadi E. Ndumele, Christie Mitchell Ballantyne, Jarrett D. Berry, Justin Basile Echouffo-Tcheugui · 2026 · JAMA Cardiology
29. Risk of Heart Failure Hospitalization for GLP-1 Receptor Agonists Versus DPP-4 Inhibitors or SGLT-2 Inhibitors in Patients With Type 2 Diabetes: A Target Trial Emulation
    Yang Xu, Tao Huang, Yue Zhang, Dongze Ji, Katherine R. Tuttle, Juan Jesús Carrero, Edouard L Fu · 2026 · Circulation
30. Aging and Heart Failure with Preserved Ejection Fraction
    Kathryn F. Larson, Awais Malik, Frank V. Brozovich · 2022 · Comprehensive physiology
31. Understanding the Progression of Congestive Heart Failure of Type 2 Diabetes Patient Using Disease Network and Hospital Claim Data
    Md Ekramul Hossain, Arif M. Khan, Shahadat Uddin · 2019 · Studies in computational intelligence
32. Intersection Between Diabetes and Heart Failure: Is SGLT2i the “One Stone for Two Birds” Approach?
    Qing Zhang, Yu Kang, Siqi Tang, Cheuk‐Man Yu · 2021 · Current Cardiology Reports
33. Systematic Review and Meta-Analysis to Predict Mortality in Heart Failure with Preserved Ejection Fraction: Development and Validation of the HF-DANAS Score
    Chuanhe Wang, Lin Guan, Han Su, Fei Tong, Ying Li, Zhichao Li, Hao Sun, Zhijun Sun · 2024 · ESC Heart Failure
34. Diabetic ketoacidosis and hyperosmolar hyperglycemic state in diabetes patients with heart failure: insight from the National inpatient sample
    Hasan Alroobi, S. Dargham, Z. Mahfoud, Amin Jayyousi, J. Al Suwaidi, Charbel Abi Khalil · 2025 · BMC Cardiovascular Disorders
35. Prevalent Diabetes Mellitus: Mortality and Management in Norwegian Heart Failure Outpatients
    Viera Stubnova, Ingrid Os, Morten Grundtvig, Bård Endre Waldum-Grevbo · 2016 · Cardiology
36. Potentially modifiable factors to reduce severity of COVID-19 in type 2 diabetes
    Nikhil V. Dhurandhar, Md Akheruzzaman, Vijay K. Hegde · 2020 · Nutrition and Diabetes
37. Assessing clinical and biomarker characteristics to optimize the benefits of sacubitril/valsartan in heart failure
    Sheldon E. Litwin, Cara Anne East · 2022 · Frontiers in Cardiovascular Medicine
38. Burden and predictors of heart failure treatment outcomes in Ethiopia: A systematic review and meta-analysis protocol
    Firomsa Bekele, Lalise Tafese, Bayisa Garbessa, Shimalis Tadasa Fayisa, Ginenus Fekadu · 2023 · PLoS ONE
39. Insulin Resistance in Heart Failure: Widening the Divide Between Reduced and Preserved Ejection Fraction?
    Stephen John Greene, Gregg C. Fonarow · 2015 · European Journal of Heart Failure
40. Editorial: Heart Failure in Type 2 Diabetes – The “Forgotten” Complication
    Cristian Guja, Rucsandra Dănciulescu Miulescu · 2018 · Romanian Journal of Diabetes Nutrition and Metabolic Diseases
41. Clinical features, management and mortality in diabetic and non-diabetic patients with heart failure – observations from the COMMIT-HF registry
    Łukasz Siedlecki, Bożena Szyguła‐Jurkiewicz, Łukasz Pyka, Bogumiła Król, Wioletta Szczurek, Mariusz Gąsior · 2017 · Polish Journal of Cardio-Thoracic Surgery
42. Impact of type 2 diabetes on life expectancy and role of kidney disease among inpatients with heart failure in Switzerland: an ambispective cohort study
    Dante Salvador, Arjola Bano, Faina Wehrli, Valentina González-Jaramillo, Markus Wolfgang Laimer, Lukas Hunziker, Taulant Muka · 2023 · Cardiovascular Diabetology
43. A new nomogram to predict in-hospital mortality in patients with acute decompensated chronic heart failure and diabetes after 48 Hours of Intensive Care Unit
    Linlin Liu, Lei Feng, Cheng Lü, Jiehan Zhang, Ya Zhao, Lin Che · 2024 · BMC Cardiovascular Disorders
44. Diabetes Treatment with Dapagliflozin and Its Combinations: Insights from Clinical Practice
    Akshay Ashok Bafna, Ajit Mehta, Rajeev Garg, Jayagopal Pathiyil Balagopalan, Rajesh Rajput, Nitin Zalte, Preethi Naik, Amarnath Sugumaran, Senthilnathan Mohanasundaram · 2024 · Journal of Diabetology
45. Heart Failure Prevention
    Ziad A. Taimeh, Daniel A. Duprez, Daniel J. Garry · 2017 · Springer eBooks
46. Anti-atherosclerotic effect of incretin mimetics: a meta-analysis of randomized controlled trials
    Mahmoud Barbarawi, Ahmed Aburahma, Yazan Zayed, Mohammed Osman, Laith Rashdan, Bakr Swaid, Ghassan I. Bachuwa · 2018 · Journal of Community Hospital Internal Medicine Perspectives
47. Optimising the Heart Failure Treatment Pathway: The Role of SGLT2 Inhibitors
    Marc Evans, Angharad R. Morgan, Zaheer R Yousef, Gethin Ellis, Umesh Kumar Dashora, Dipesh Patel, Pam Brown, Wasim Hanif, Johnathan N. Townend, Naresh Kanumilli et al. · 2021 · Drugs
48. Obesity 2021: Current Clinical Management of a Chronic, Serious Disease
    Kushner · 2021 · The Journal of Family Practice
49. Outcomes of Patients With Diabetes Versus Patients Without Diabetes Hospitalized With Acute Heart Failure
    Siu‐Hin Wan, Joshua P. Slusser, David O. Hodge, Horng H. Chen · 2021 · The American Journal of Cardiology
50. Influence of diabetes on mortality and ICD therapies in ICD recipients: a systematic review and meta-analysis of 162,780 patients
    Hualong Liu, Jinzhu Hu, Wen Zhuo, Rong Wan, Kui Hong · 2022 · Cardiovascular Diabetology
51. Risk Factors of Secondary Cardiovascular Events in a Multi-Ethnic Asian Population with Acute Myocardial Infarction: A Retrospective Cohort Study from Malaysia
    Sophia Rasheeqa Ismail, Mohd Shawal Faizal Mohammad, Adam S. Butterworth, Rajiv Chowdhury, John Danesh, Emanuele Di Angelantonio, Simon J. Griffin, Lisa A M Pennells, Angela Wood, Mohd Fairulnizal Md Noh et al. · 2023 · Journal of Cardiovascular Development and Disease
52. Screening for Autoantibodies in Type 1 Diabetes: A Call to Action
    Петерс · 2021 · The Journal of Family Practice
53. Prognostic value of glycemic variability in patients with decompensated chronic heart failure and diabetes mellitus
    М Ю Юрьева, Irina Vladimirovna Dvoryashina · 2017 · Kardiologiia
54. Role of Continuous Glucose Monitoring in Diabetic Patients at High Cardiovascular Risk: an Expert-based Multidisciplinary Delphi Consensus
    Carlo Di Mario, Stefano Genovese, Gaetano Antonio Lanza, Edoardo Mannucci, Giancarlo Marenzi, Edoardo Sciatti, Dario Pitocco · 2022 · Research Square
55. Effect of fenofibrate on blood lipid, sICAM-1, ET-1 and prognosis in chronic heart failure patients complicated with diabetes
    Xiuli Liu, Jifeng Zhang, Wenzong Zhou, J Liu, Yingli Wang · 2023 · Cellular and Molecular Biology
56. Regional variation in cause of death in patients with type 2 diabetes: Insights from EXSCEL
    Vishal N. Rao, Abhinav Sharma, Amanda S. Stebbins, John B. Buse, Brian G. Katona, Neha Jadeja Pagidipati, Rury R. Holman, Adrian F. Hernandez, Robert John Mentz, Renato D. Lópes · 2024 · American Heart Journal
57. Acute effects of empagliflozin on open-loop baroreflex function and urine output in streptozotocin-induced type 1 diabetic rats
    Toru Kawada, Hiromi Yamamoto, Masafumi Fukumitsu, Takuya Nishikawa, Hiroki Matsushita, Yuki Yoshida, Kei Sato, Hidetaka Morita, Joe Alexander, Keita Saku · 2024 · The Journal of Physiological Sciences
58. The Role of the Diabetes Care and Education Specialist in Caring for Diabetes Complications and Common Comorbid Conditions
    Anne Misher, Jennifer L. Rosselli, Christie Schumacher, Michael See · 2021 · ADCES in Practice
59. Is There a Diabetes–Kidney–Heart Continuum? Perspectives From the Results of the Cardiovascular and Renal Outcome Clinical Trials With SGLT2 Inhibitors
    Liwen Bao, Xiufang Gao, Kun Xie, Yong Li · 2021 · Frontiers in Cardiovascular Medicine
60. Diversity and Traditional Use Value of Medicinal Plants in Bou Saada District of M’Sila Province, South East Algeria
    Hanane Khalfa, Khellaf Rebbas, Mohamed Djamel Mıara, Hamdi Bendıf, Ahmed Boufissiou, Nabila Souilah, Nassera Daoud, A Peroni · 2023 · Journal of Biodiversity Conservation and Bioresource Management
61. Emirates consensus recommendations on cardiovascular risk management in type 2 diabetes
    Hani Mohamed Sabbour, Wael A. Almahmeed, Fatheya Alawadi, Abdullah Mohammed Shehab, Abdulamjeed Al Zubaidi, Alaaeldin M. Bashier, Abdul Rauf Ghulam, Fouzia Rashid, Hosam Zaky, Hussien Heshmat Kassem et al. · 2025 · Frontiers in Endocrinology
62. Revolutionizing Cardiac Care: Artificial Intelligence Applications in Heart Failure Management
    Areeba Fareed, Rayyan Vaid, Abdulrahmon Akanmu Moradeyo, Afra Sohail, Ayesha Sarwar, Aashar Khalid · 2025 · Cardiology in Review
63. Identify of blood glucose metabolism regulation pathways and related proteins in the db/db mouse model through iTRAQ quantitative mass spectrometry
    Yilin Yue, Shanshan Dong, Zhihui Wu, Yongqing Dong, Qingpei Chen, Hong Wang, Chaowu Liu, Deguang Yang · 2025 · Acta Diabetologica
64. Vércukorcsökkentő gyógyszerek biztonságossága szívelégtelenségben
    Attila Frigy, Márta Germán-Salló, Lehel Máthé, Mónika Szabó · 2017 · Orvosi Hetilap
65. Recognition and Management of a Less Common Cause of Chronic Kidney Disease: Autosomal Dominant Polycystic Kidney Disease
    Weir · 2020 · The Journal of Family Practice
66. Recognition and Management of Hypoglycemia
    Shubrook · 2020 · The Journal of Family Practice
67. Antidiabetic Effect of Piper Sarmentosum: A Systematic Review
    Mirrah Nisa Azhar, Farrah Shafeera Ibrahim, Naleena Devi Muniandy · 2022 · Malaysian Journal of Medicine and Health Sciences
68. Role of Therapeutic Potential, Contemporary Management, Unmet needs of SGLT2 Inhibitors in Congestive Heart Failure
    Mukesh Nandave · 2024 · Springer eBooks
69. Harmony in Chaos: Deciphering the Influence of Ischemic Cardiomyopathy and Non-Cardiac Comorbidities on Holter ECG Parameters in Chronic Heart Failure Patients: A Pilot Study
    Ștefania-Teodora Duca, Minerva Codruța Bădescu, Alexandru Dan Costache, Adriana Chetran, Radu-Ştefan Miftode, Ionuț Tudorancea, Ovidiu Mitu, Irina Afrăsânie, Radu Ciorap, Ionela-Lăcrămioara Șerban et al. · 2024 · Medicina
70. Diabetes as a Predictor of In-Hospital and One-Year Outcomes After Decompensated Heart Failure
    Enrique B. Fairman, Flavio A. Delfino, Víctor Miguel Mauro, Adrián A. Charask, Yanina Castillo Costa, Alesis Raffaeli, Lucas Rojo, Valentina Rodríguez Rowain, Leonardo Cáceres, Carlos Barrero · 2020 · Current Problems in Cardiology
71. Compliance with Prescription Guidelines for Glucose-Lowering Therapies According to Renal Function: Real-Life Study in Inpatients of Internal Medicine, Endocrinology and Cardiology Units
    Laura Lohan, Florence Galtier, Thibault Manson, Thibault Mura, Audrey Castet‐Nicolas, Delinger Faure, Nicolas Chapet, Florence Leclercq, Jean‐Luc Pasquié, François Roubille et al. · 2021 · Medicina
72. Beyond HbA1c cardiovascular protection in type 2 diabetes mellitus
    Umar Gati Adamu, Dineo Mpanya, Anupa K. Patel, Nqoba Tsabedze · 2022 · Journal of Endocrinology Metabolism and Diabetes of South Africa
73. The Impact of Diabetes on Haemodynamic and Cardiometabolic Responses in Heart Failure With Preserved Ejection Fraction
    Emilia Nan Tie, Shane Nanayakkara, Donna Vizi, Justin A. Mariani, David M. Kaye · 2024 · Heart Lung and Circulation
74. Sex and Age Differences in the Impact of Metabolic Syndrome on Heart Failure Development
    Tae‐Eun Kim, Do Young Kim, Hyeongsu Kim, Sung Hea Kim · 2024 · Metabolites
75. Management of diabetes in patients hospitalized for acute cardiac events: Joint position paper from the French Society of Cardiology and the French-speaking Diabetes Society
    Patrick Henry, Sophie Jacqueminet, Gilles Lemesle, Gaëtan Prévost, Boccara, Emmanuel Cosson, Étienne Puymirat, Denis Angoulvant, François Roubille, Serge Kownator et al. · 2025 · Archives of cardiovascular diseases
76. Glycohemoglobin Variations and Long-term Risk of Incident Heart Failure in Patients With Type 2 Diabetes
    Fu‐Chih Hsiao, Chia‐Pin Lin, Tzyy‐Jer Hsu, Ying‐Chang Tung, Yi‐Hsin Chan, Shao‐Wei Chen, Pao‐Hsien Chu · 2025 · Mayo Clinic Proceedings
77. Admission blood glucose as a prognostic indicator in patients with acute myocardial infarction
    Raisul Russel, R. Ranjith, Benn K. D. Sartorius · 2019 · SA Heart
78. Predictive Factors on the Incidence of Heart Failure in Patients with Ischemic Heart Disease: Using a 10-Year Population-Based Korea National Health Insurance Cohort Data
    Seon Young Hwang, Kyung-Ae Kim, Oh Jong Choi · 2020 · International Journal of Environmental Research and Public Health
79. Диабетическая кардиомиопатия: классификация, инструментальные методы диагностики
    Alexandr A. Serhiyenko, Victoria A Serhiyenko · 2020 · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
80. Mechanisms-based therapeutic strategies in type 2 diabetes.
    Francesco Paneni, Sarah Costantino · 2015 · PubMed Central
81. Natriuretic Peptide System Activation in Acute Heart Failure Patients with Diabetes
    Filipe Manuel Cunha, Joana Certo Pereira, Pedro Sousa Marques, Helena Moreira, Pedro Rodrigues, Maria João Pinto, Patrícia Lourenço, Paulo Bettencourt · 2017 · Journal of Diabetes Research
82. A rat model of enhanced glycation mimics cardiac phenotypic components of human type 2 diabetes : A translational study using MRI
    João Castelhano, Bruno Ribeiro, Mafalda Sanches, Bruno Graça, Joana C. Saraiva, Bárbara Oliveiros, Christian Neves, Tiago Rodrigues, José Sereno, Sonia I. Goncalves et al. · 2020 · Journal of Diabetes and its Complications
83. Prevalence, clinical characteristics, and echocardiographic phenotypes of heart failure in patients with type 2 diabetes mellitus
    N.B. Yeshniyazov, Vadim Medovchshikov, Ayten Fuadovna Safarova, Э. Р. Хасанова, Zhanna D. Kobalava · 2020 · Clinical pharmacology and therapy
84. Diabetes, gender and deterioration in estimated glomerular filtration rate in patients with chronic heart failure: Ten-year prospective cohort study
    Jessica Kearney, Michael Drozd, Andrew MN Walker, Thomas A Slater, Sam Straw, John Gierula, Maria F. Paton, Judith E. Lowry, Charlotte A. Cole, Klaus K. Witte et al. · 2021 · Diabetes and Vascular Disease Research
85. Risk prediction of chronic heart failure in patients with type 2 diabetes
    Volha Vasilkova, Tatiana V. Mokhort, Irina Savasteeva, Ivan Yu. Pchelin, Yu. I. Yarets, Л. Е. Коротаева · 2021 · Juvenis scientia
86. Higher body mass index and disease duration are associated with increased risk of left ventricular diastolic dysfunction in women with systemic lupus erythematosus
    Pamela Munguía‐Realpozo, Claudia Mendoza Pinto, Mario García‐Carrasco, Ricardo Orlando Escarcega, Roberto Berra‐Romani, Ivet Etchegaray‐Morales, Liliana Pérez-Aquino, Adalberto Ramírez-Hernández, Socorro Méndez‐Martínez, Ricard Cervera · 2022 · Lupus
87. Diabetes mellitus does not alter mortality or hospitalisation risk in patients with newly diagnosed heart failure with preserved ejection fraction: Time to rethink pathophysiological models of disease progression
    John Gierula, Sam Straw, Charlotte A. Cole, Judith E. Lowry, Maria F. Paton, Melanie McGinlay, Klaus Karl Witte, Peter J. Grant, Stephen Bentley Wheatcroft, Michael Drozd et al. · 2024 · Diabetes and Vascular Disease Research
88. Detection of Glycemia and Osmolarity Changes Using Eye Examinations
    Şahbender Koç, Selçuk Baysal, Zuhal Koç Apaydın, Arif Ülkü Yener · 2018 · Metabolic Syndrome and Related Disorders
89. Heart failure in diabetes: From an increased risk to a treatment target
    Eberhard Standl · 2018 · Diabetes Mellitus
90. Unraveling the association of heart failure from drug and disease: Insights from recent cardiovascular trials in type 2 diabetes mellitus
    Matthew N. Peters, Jeremy S. Pollock, Sanjay Rajagopalan · 2015 · Journal of Diabetes and its Complications
91. Predictive Modelling of the Comorbidity of Chronic Diseases: A Network and Machine Learning Approach
    Ekramul Hossain · 2020 · The Sydney eScholarship Repository (The University of Sydney)
92. Adipose-derived mesenchymal stem cells (ADMSCs) protect against hyperglycemia and hyperlipidemia-induced heart failure by inhibiting autophagy-related apoptosis
    Xu Xu, Lingyun Tao, Jie Zhou, Jing Ni · 2021 · Research Square
93. Right Ventricular Dysfunction and Exercise Impairment in Patients with Heart Failure, Insulin Resistance, and Diabetes Mellitus: Insights from the T.O.S.CA. Registry (Cardiovascular Diabetology 2022)
    Giuseppe Lisco, Domenico Triggiani · 2023 · Endocrine Metabolic & Immune Disorders - Drug Targets
94. Diabetes mellitus is associated with low exercise capacity and impaired peripheral vasodilation in patients with heart failure − a propensity score-matched study
    Miroslava Valentová, Mirela Vatic, Tania Garfias‐Veitl, Anja Sandek, Tarek Bekfani, Ewa Anita Jankowska, John G.F. Cleland, Andrew L. Clark, Mitja Lainščak, Ali Ahmed et al. · 2024 · Diabetes Research and Clinical Practice
95. Reprogramming of lipids and amino acids metabolism is an early event in myocardium of type 1 diabetic rhesus monkeys
    Min Zhu, Wen Liu, Shan Su, Meng Gong, Guangneng Liao, Fudong Fu, Gen Chen, Zhiyong Rao, Jingqiu Cheng, Jingping Liu et al. · 2025 · Journal of Pharmaceutical and Biomedical Analysis
96. Visit-to-Visit Variability in Lipid Levels and Risk of Incident Heart Failure in Adults With Type 2 Diabetes
    Arnaud D. Kazé, Chiadi E. Ndumele, Seth Shay Martin, Prasanna Santhanam, Beeletsega T. Yeneneh, Farouk Mookadam, Roderick H. Tung, Gregg C. Fonarow, Justin Basile Echouffo-Tcheugui · 2025 · Diabetes Care
97. Management of diabetes in patients hospitalized for acute cardiac events: Joint position paper from the French Society of Cardiology and the French-speaking Diabetes Society
    Patrick Henry, Sophie Jacqueminet, Gilles Lemesle, Gaëtan Prévost, Franck Boccara, Emmanuel Cosson, Étienne Puymirat, Denis Angoulvant, François Roubille, Serge Kownator et al. · 2025 · Diabetes & Metabolism
98. Incidence of first hospitalization for heart failure in type 2 diabetes mellitus: A population-based cohort study in primary care.
    M. Muñoz, V. Cendrós, E. Navas, J. Verdú-Rotellar, J. Barrot, J. Franch · 2025 · Primary Care Diabetes
99. Interrelationship Between Cardiopulmonary Exercise Testing Indices and Markers of Subclinical Cardiovascular Dysfunction in Those with Type 2 Diabetes—An Observational Cross-Sectional Analysis
    Grace W. M. Walters, Gaurav Singh Gulsin, Joseph J. Henson, Stavroula Argyridou, Kelly S. Parke, Thomas E. Yates, Melanie Jane Davies, Gerry Patrick McCann, Emer M. Brady · 2025 · Journal of Functional Morphology and Kinesiology
100. Pretransplant Diabetes Mellitus and Obesity in Recipients Is Associated With Reduced Survival Following Donation After Circulatory Death Heart Transplantation
     Yeahwa Hong, Umar Nasim, Ander Dorken‐Gallastegi, Nidhi Iyanna, Brian E. Woolley, Samantha N. Machinski, Gavin Hickey, Mary Keebler, Edward T. Horn, David J. Kaczorowski · 2025 · Clinical Transplantation